TrialTransplantation and cellular therapy2024

N-803, an IL-15 Superagonist Complex as Maintenance Therapy After Allogeneic Donor Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndrome; A Phase 2 Trial.

Aimee Merino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.